Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Queensland Health
Teva
Citi
Farmers Insurance

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 7,728,010

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,728,010
Title:Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
Abstract: New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Inventor(s): Amiri; Payman (Walnut Creek, CA), Fantl; Wendy (San Francisco, CA), Hansen; Teresa (Danville, CA), Levine; Barry Haskell (Lafayette, CA), McBride; Christopher (Oakland, CA), Poon; Daniel J (Oakland, CA), Ramurthy; Savithri (Walnut Creek, CA), Renhowe; Paul A (Danville, CA), Shafer; Cynthia M (El Sobrante, CA), Subramanian; Sharadha (San Ramon, CA), Sung; Leonard (Irvine, CA)
Assignee: Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA)
Application Number:11/282,939
Patent Claims:see list of patent claims

Details for Patent 7,728,010

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) ➤ Sign Up RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,728,010

Country Patent Number Publication Date
South Africa 200408386 May 31, 2006
South Africa 200603418 Jul 25, 2007
World Intellectual Property Organization (WIPO) 03082272 Oct 09, 2003
World Intellectual Property Organization (WIPO) 2005032548 Apr 14, 2005
United States of America 2004087626 May 06, 2004
United States of America 2004122237 Jun 24, 2004
United States of America 2007299039 Dec 27, 2007
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Colorcon
QuintilesIMS
McKesson
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.